Trial intelligence / Profile preview

Comparison of Metvix PDT with vehicle in photoaged skin

2006-004237-15Phase 2Completed

Sponsor
Galderma
Start
Jan 2007
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of methyl aminolevulinate in photoaging, Mottled hyperpigmentation, sponsored by Galderma. Started Jan 2007; status: completed.

02

Drugs

methyl aminolevulinate
03

Conditions

photoagingMottled hyperpigmentation

Beyond the preview

Go deeper on 2006-004237-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004237-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call